Market research
NBY NovaBay Pharmaceuticals, Inc
NYSE MKT USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 52M
- P/E ratio
- Not available
- Analyst target
- 0.85
- Dividend yield
- 0.0%
- Beta
- 0.16
Community
Investor discussion
1 comment
Sign in to join the NBY discussion.
5 years, 4 months ago
NovaBay Pharmaceuticals, Inc is currently in a long term downtrend where the price is trading 23.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.3.
NovaBay Pharmaceuticals, Inc's total revenue rose by 10.8% to $2M since the same quarter in the previous year.
Its net income has increased by 99.9% to $-2K since the same quarter in the previous year.
Finally, its free cash flow fell by 1.6% to $-1M since the same quarter in the previous year.
Based on the above factors, NovaBay Pharmaceuticals, Inc gets an overall score of 3/5.